WOCKHARDT
Back to Cashflow Statement
|
WOCKHARDT Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹334 Cr | ₹-315 Cr | ₹-71 Cr | ₹-1,171 Cr | ₹-680 Cr |
What is the latest Cash Flow from Financing Activities ratio of WOCKHARDT ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹334 Cr |
Mar2023 | ₹-315 Cr |
Mar2022 | ₹-71 Cr |
Mar2021 | ₹-1,171 Cr |
Mar2020 | ₹-680 Cr |
How is Cash Flow from Financing Activities of WOCKHARDT Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹334 Cr | Positive | |
Mar2023 | ₹-315 Cr | Negative | |
Mar2022 | ₹-71 Cr | Negative | |
Mar2021 | ₹-1,171 Cr | Negative | |
Mar2020 | ₹-680 Cr | - |
Compare Cash Flow from Financing Activities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹26,040.6 Cr | 1.9% | 15.5% | 262.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 1.9% |
15.5% |
262.3% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses